Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

Epidemiologic Approaches to Evaluating the Potential for Human Papillomavirus Type Replacement Postvaccination

(2013) J. E. Tota et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact

(2013) Kimberley Kavanagh et al.   BMC INFECTIOUS DISEASES

Achieving high and equitable coverage of adolescent HPV vaccine in Scotland

(2013) Katy Sinka et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

(2013) A. Szarewski et al.   JOURNAL OF INFECTIOUS DISEASES

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

(2012) S. N. Tabrizi et al.   JOURNAL OF INFECTIOUS DISEASES

The value of HPV vaccination

(2012)   NATURE MEDICINE

Human Papillomavirus Vaccine Introduction – The First Five Years

(2012) Lauri E. Markowitz et al.   VACCINE

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine

(2012) Cecilia M. Roteli-Martins et al.   Human Vaccines & Immunotherapeutics

Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx

(2011) E Junor et al.   BRITISH JOURNAL OF CANCER

HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland

(2011) M C O'Leary et al.   BRITISH JOURNAL OF CANCER

Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines

(2011) Barbara Romanowski   Human vaccines & immunotherapeutics

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

(2011) Aimée R. Kreimer et al.   JNCI-Journal of the National Cancer Institute

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

(2011) Julia ML Brotherton et al.   LANCET

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

(2011) Aimée R Kreimer et al.   LANCET ONCOLOGY

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Cosette M Wheeler et al.   LANCET ONCOLOGY

Acceptability and response to a postal survey using self-taken samples for HPV vaccine impact monitoring

(2011) K. Sinka et al.   SEXUALLY TRANSMITTED INFECTIONS

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines

(2010) K Cuschieri et al.   BRITISH JOURNAL OF CANCER

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY